CEACAM5 and neoplasm: When the χ2 test was used to examine the rate of positivity for each of the three tumour markers in the sera of patients with recurrence, significant differences between CYFRA 21-1 and CEA (P<0.0001) and between CYFRA 21-1 and CA 15-3 (P<0.0003) were observed.